Saturday, August 20, 2022

New laboratories for growing Nottingham CRO see company triple footprint

Contract research organisation (CRO) Cellomatics Biosciences has moved into new purpose-built premises in Nottingham in the wake of rising demand for its bespoke preclinical and early drug discovery phase laboratory services.

The company’s new facilities in Colwick, Nottingham represent a three-fold increase in the company’s footprint, allowing room for further expansion. The purpose-built facility is an independent building covering approximately 5,500 sq ft of space across two levels.

The ground floor is dedicated to laboratory facilities, whilst the first floor provides scientific write-up space, offices, and meeting rooms. The new laboratories are equipped with state-of-the-art imaging and analysis equipment and Class ll biological safety cabinets, fridges, freezers, and CO2 incubators.

Employing 15 people, Cellomatics was founded in 2015 and specialises in the development of bespoke bioassays across numerous therapeutic areas including oncology, immuno-oncology, immunology, inflammation and respiratory.

The company has doubled its revenue over the last three years, and is on-track to record further growth, as Cellomatics’ CEO and founder, Dr Shailendra Singh explains: “Drug development is a truly global market and the number of biotechs, pharma companies and academic groups working on the translation of ideas into medicines continues to increase, and as does the funding available to support such projects.

“The changing dynamic of the industry means that companies are increasingly looking to specialist CROs for the expertise they need. Our bespoke service delivers critical data at an early stage through innovative solutions to complex testing requirements – an approach which has cumulated in repeat business and helped us to build a strong reputation in the market.”

“We are delighted to be expanding our footprint in Nottingham,” Shailendra says. “The city sits at the heart of the UK’s thriving preclinical CRO sector in the East Midlands and affords access to talent and expertise from both the local universities and the scientific industry. Our new state-of-the-art facilities provide a collaborative working environment for our valued workforce, and will enable us to accelerate our plans for further recruitment and to attract the very best scientists to Cellomatics.”

Stuart Gibson, finance director at Cellomatics, says: “Cellomatics is well-positioned to double top-line organic revenue over the next two years through expansion into new markets, focusing on new therapeutic areas, developing or acquiring new technologies, and building new service offerings.

“We also plan to partner with strategic investors to further accelerate our growth. As a company, we are committed to developing additional capabilities to enhance the depth of our services within our current specialist sectors, and to expand into other growing sectors.”

Shailendra Singh adds: “Going forward, we will continue to invest in our technical expertise to meet the global demand, and to accelerate the rate of our export business. Indeed, to fulfil our ambitions of delivering exponential growth in revenue and shareholder value across the next few years, we will continue to invest in our scientific capabilities, technologies, and services to support us in delivering and adding value to more client projects.”

Cellomatics Biosciences was recently awarded the Queen’s Award for Enterprise for International Trade.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £33.60 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.